The downgrade from Buy to Neutral by UBS indicates a less optimistic outlook for the company's stock. The lowering of the price target from $70 to $66 also suggests that the analyst believes the stock may not perform as well as previously expected. This could potentially lead to a decrease in the stock's price in the short term.